Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice

Behavioural Brain Research

Volumn 311, Issue , 2016, Pages 131-140

  Kesby, James P ^a,b   Markou, Athina ^a   Semenova, Svetlana ^a   Grant, Igor ^b   Ellis, Ronald J ^b   Letendre, Scott L ^b   Achim, Cristian L ^b   Cherner, Mariana ^b   Morgan, Erin E ^b   Carr, Aaron M ^b   Heaton, Robert K ^b   Hampton Atkinson, J ^b   Marcotte, Thomas D ^b   Dawson, Matthew ^b   Brown, Gregory G ^b   Liu, Thomas T ^b   Scadeng, Miriam ^b   Fennema Notestine, Christine ^b   Archibald, Sarah L ^b   Hesselink, John R ^b   Meloy, Mary Jane ^b   Stark, Craig E L ^b   Kaul, Marcus ^b   Soontornniyomkij, Virawudh ^b   Lipton, Stuart A ^b   Iudicello, Jennifer E ^b   Gongvatana, Assawin ^b   Schrier, Rachel D ^b   Massanella, Marta ^b   Gamst, Anthony C ^b   Cushman, Clint ^b   Vaida, Florin ^b   Abramson, Ian S ^b   Deutsch, Reena ^b   Umlauf, Anya ^b   Marquie Beck, Jennifer ^b   Minassian, Arpi ^b   Perry, William ^b   Geyer, Mark A ^b   Young, Jared W ^b   Grethe, Amanda B ^b   Tapert, Susan F ^b   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

AIDS; Barnes maze; Dopamine; Glutamate; L Deprenyl; Prefrontal cortex

Indexed keywords

DOPAMINE; DOXYCYCLINE; GLUTAMIC ACID; GLUTAMINE; MONOAMINE; SELEGILINE; SEROTONIN; TRANSACTIVATOR PROTEIN; MONOAMINE OXIDASE INHIBITOR;

AMINO ACID BRAIN LEVEL; ANALYTICAL ERROR; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BARNES MAZE TEST; COGNITION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DORSAL STRIATUM; DRUG MECHANISM; FACILITATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LEARNING; MALE; MEMORY CONSOLIDATION; MONOAMINE METABOLISM; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECALL; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SIGNAL TRANSDUCTION; SPATIAL MEMORY; TASK PERFORMANCE; TRANSGENIC MOUSE; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; MAZE TEST; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; DOPAMINE; GENE EXPRESSION; GENE PRODUCTS, TAT; GLUTAMIC ACID; GLUTAMINE; HIV; MALE; MAZE LEARNING; MENTAL RECALL; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOAMINE OXIDASE INHIBITORS; REVERSAL LEARNING; SELEGILINE; SEROTONIN; SPATIAL MEMORY;

EID: 84973102879     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.05.034     Document Type: Article

References (49)

1. Heaton R.K., Grant I., Butters N., White D.A., Kirson D., Atkinson J.H., McCutchan J.A., Taylor M.J., Kelly M.D., Ellis R.J., et al. The HNRC 500: neuropsychology of HIV infection at different disease stages. J. Int. Neuropsychol. Soc. 1995, 1:231-251.
2. Heaton R.K., Franklin D.R., Ellis R.J., McCutchan J.A., Letendre S.L., LeBlanc S., Corkran S.H., Duarte N.A., Clifford D.B., Woods S.P., Collier A.C., Marra C.M., Morgello S., Mindt M.R., Taylor M.J., Marcotte T.D., Atkinson J.H., Wolfson T., Gelman B.B., McArthur J.C., Simpson D.M., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I., Charter H. Grp HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 2011, 17:3-16.
3. Lindl K.A., Marks D.R., Kolson D.L., Jordan-Sciutto K.L. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J. Neuroimmune Pharmacol. 2010, 5:294-309.
4. Kesby J.P., Heaton R.K., Young J.W., Umlauf A., Woods S.P., Letendre S.L., Markou A., Grant I., Semenova S. Methamphetamine exposure combined with HIV-1 disease or gp120 expression: comparison of learning and executive functions in humans and mice. Neuropsychopharmacology 2015, 40:1899-1909.
5. Gorry P.R., Ong C., Thorpe J., Bannwarth S., Thompson K.A., Gatignol A., Wesselingh S.L., Purcell D.F.J. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr. HIV Res. 2003, 1:463-473.
6. Li W.X., Li G.H., Steiner J., Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox. Res. 2009, 16:205-220.
7. Hudson L., Liu J.K., Nath A., Jones M., Raghavan R., Narayan O., Male D., Everall I. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 2000, 6:145-155.
8. Parmentier H.K., Vanwichen D.F., Meyling F., Goudsmit J., Schuurman H.J. Epitopes of human-immunodeficiency-virus regulatory proteins Tat, Nef, and Rev are expressed in normal human tissue. Am. J. Pathol. 1992, 141:1209-1216.
9. Kim B.O., Liu Y., Ruan Y.W., Xu Z.C., Schantz L., He J.J. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am. J. Pathol. 2003, 162:1693-1707.
10. Ferris M.J., Frederick-Duus D., Fadel J., Mactutus C.F., Booze R.M. In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission. Synapse 2009, 63:181-185.
11. Theodore S., Cass W.A., Dwoskin L.P., Maragos W.F. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse 2012, 66:755-757.
12. Midde N.M., Gomez A.M., Zhu J. HIV-1 Tat protein decreases dopamine transporter cell Surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J. Neuroimmune Pharmacol. 2012, 7:629-639.
13. Zhu J., Mactutus C.F., Wallace D.R., Booze R.M. HIV-1 Tat protein-induced rapid and reversible decrease in H-3 dopamine uptake: dissociation of H-3 dopamine uptake and H-3 2 beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. J. Pharmacol. Exp. Ther. 2009, 329:1071-1083.
14. Castane A., Theobald D.E.H., Robbins T.W. Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats. Behav. Brain Res. 2010, 210:74-83.
15. Clark L., Cools R., Robbins T.W. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cognit. 2004, 55:41-53.
16. Leon W.C., Bruno M.A., Allard S., Nader K., Cuello A.C. Engagement of the PFC in consolidation and recall of recent spatial memory. Learn. Mem. 2010, 17:297-305.
17. Carey A.N., Sypek E.I., Singh H.D., Kaufman M.J., McLaughlin J.P. Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav. Brain Res. 2012, 229:48-56.
18. Fitting S., Ignatowska-Jankowska B.M., Bull C., Skoff R.P., Lichtman A.H., Wise L.E., Fox M.A., Su J.M., Medina A.E., Krahe T.E., Knapp P.E., Guido W., Hauser K.F. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 tat transgenic mice. Biol. Psychiatry 2013, 73:443-453.
19. Aylward E.H., Henderer J.D., McArthur J.C., Brettschneider P.D., Harris G.J., Barta P.E., Pearlson G.D. Reduced basal ganglia volume in HIV-1 associated dementia: results from quantitative neuroimaging. Neurology 1993, 43:2099-2104.
20. Kieburtz K., Ketonen L., Cox C., Grossman H., Holloway R., Booth H., Hickey C., Feigin A., Caine E.D. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch. Neurol. 1996, 53:155-158.
21. Hestad K., McArthur J.H., Dalpan G.J., Selnes O.A., Nancesproson T.E., Aylward E., Mathews V.P., McArthur J.C. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test-performance. Acta Neurol. Scand. 1993, 88:112-118.
22. Kumar A.M., Ownby R.L., Waldrop-Valverde D., Fernandez B., Kumar M. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J. Neurovirol. 2011, 17:26-40.
23. Clarke H.F., Hill G.J., Robbins T.W., Roberts A.C. Dopamine, but not serotonin regulates reversal learning in the marmoset caudate nucleus. J. Neurosci. 2011, 31:4290-4297.
24. Floresco S.B., Phillips A.G. Delay-dependent modulation of memory retrieval by infusion of a dopamine D-1 agonist into the rat medial prefrontal cortex. Behav. Neurosci. 2001, 115:934-939.
25. Schoenbaum G., Roesch M.R., Stalnaker T.A., Takahashi Y.K. A new perspective on the role of the orbitofrontal cortex in adaptive behaviour. Nat. Rev. Neurosci. 2009, 10:885-892.
26. Grace A.A., Floresco S.B., Goto Y., Lodge D.J. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 2007, 30:220-227.
27. Laux G., Volz H.P., Moller H.J. Newer and older monoamine-oxidase inhibitors-a comparative profile. CNS Drugs 1995, 3:145-158.
28. Bainbridge J.L., Page R.L., Ruscin J.M. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors. Neurol. Clin. 2008, 26. (S85-+).
29. de Lima M.N., Laranja D.C., Caldana F., Bromberg E., Roesler R., Schroder N. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp. Gerontol. 2005, 40:506-511.
30. de Lima M.N.M., Laranja D.C., Caldana F., Grazziotin M.M., Garcia V.A., Dal-Pizzol F., Bromberg E., Schroder N. Selegiline protects against recognition memory impairment induced by neonatal iron treatment. Exp. Neurol. 2005, 196:177-183.
31. Maia F.D., Pitombeira B.S.S., Araujo D.T., Cunha G.M.A., Viana G.S.B. l-deprenyl prevents lipid peroxidation and memory deficits produced by cerebral ischemia in rats. Cell. Mol. Neurobiol. 2004, 24:87-100.
32. Tsunekawa H., Noda Y., Mouri A., Yoneda F., Nabeshima T. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35). Behav. Brain Res. 2008, 190:224-232.
33. Scheller C., Sopper S., Jenuwein M., Neuen-Jacob E., Tatschner T., Grunblatt E., ter Meulen V., Riederer P., Koutsilieri E. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J. Neurochem. 2005, 95:377-387.
34. Kesby J.P., Markou A., Semenova S. TMARC, Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice. Eur. Neuropsychopharmacol. 2015, 25:141-150.
35. Kesby J.P., Kim J.J., Scadeng M., Woods G., Kado D.M., Olefsky J.M., Jeste D.V., Achim C.L., Semenova S. Spatial cognition in adult and aged mice exposed to high-fat diet. PLoS One 2015, 10:e0140034.
36. Groves N.J., Kesby J.P., Eyles D.W., McGrath J.J., Mackay-Sim A., Burne T.H.J. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice. Behav. Brain Res. 2013, 241:120-131.
37. Kesby J.P., Cui X., Ko P., McGrath J.J., Burne T.H., Eyles D.W. Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci. Lett. 2009, 461:155-158.
38. Paris J.J., Singh H.D., Ganno M.L., Jackson P., McLaughlin J.P. Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl.) 2014, 231:2349-2360.
39. Harricharan R., Thaver V., Russell V.A., Daniels W.M. Tat-induced histopathological alterations mediate hippocampus-associated behavioural impairments in rats. Behav. Brain Funct.: BBF 2015, 11:3.
40. Graybeal C., Feyder M., Schulman E., Saksida L.M., Bussey T.J., Brigman J.L., Holmes A. Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF. Nat. Neurosci. 2011, 14:1507-1509.
41. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.L., Heaton R.K., Ellis R.J., Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am. J. Psychiatry 2005, 162:1461-1472.
42. Melrose R.J., Tinaz S., Castelo J.M.B., Courtney M.G., Stern C.E. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav. Brain Res. 2008, 188:337-347.
43. Weis S., Haug H., Budka H. Astroglial changes in the cerebral-cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol. Appl. Neurobiol. 1993, 19:329-335.
44. Gillan C.M., Robbins T.W. Goal-directed learning and obsessive-compulsive disorder. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369.
45. Cisneros I.E., Ghorpade A. HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Curr. HIV Res. 2012, 10:392-406.
46. Sailasuta N., Ross W., Ananworanich J., Chalermchai T., DeGruttola V., Lerdlum S., Pothisri M., Busovaca E., Ratto-Kim S., Jagodzinski L., Spudich S., Michael N., Kim J.H., Valcour V., R.S.P.Teams Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One 2012, 7.
47. Dickens A.M., Anthony D.C., Deutsch R., Mielke M.M., Claridge T.D., Grant I., Franklin D., Rosario D., Marcotte T., Letendre S., McArthur J.C., Haughey N.J. Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS 2015, 29:559-569.
48. Samikkannu T., Atluri V.S., Arias A.Y., Rao K.V., Mulet C.T., Jayant R.D., Nair M.P. HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders. Curr. HIV Res. 2014, 12:397-405.
49. Mishra N., Sasmal D. Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor. Brain Res. 2012, 1470:45-51.